Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP563591.RAGcDkMURkyB6Gv7lEN7lQVrjd5XVXqzVEDwk-vr7aGfo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP563591.RAGcDkMURkyB6Gv7lEN7lQVrjd5XVXqzVEDwk-vr7aGfo130_assertion type Assertion NP563591.RAGcDkMURkyB6Gv7lEN7lQVrjd5XVXqzVEDwk-vr7aGfo130_head.
- NP563591.RAGcDkMURkyB6Gv7lEN7lQVrjd5XVXqzVEDwk-vr7aGfo130_assertion description "[A substantial percentage of brain tumors overexpressed biomarkers associated with drug resistance, including MGMT (67%), GSTP1 (49%), and mutant p53 (41%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP563591.RAGcDkMURkyB6Gv7lEN7lQVrjd5XVXqzVEDwk-vr7aGfo130_provenance.
- NP563591.RAGcDkMURkyB6Gv7lEN7lQVrjd5XVXqzVEDwk-vr7aGfo130_assertion evidence source_evidence_literature NP563591.RAGcDkMURkyB6Gv7lEN7lQVrjd5XVXqzVEDwk-vr7aGfo130_provenance.
- NP563591.RAGcDkMURkyB6Gv7lEN7lQVrjd5XVXqzVEDwk-vr7aGfo130_assertion SIO_000772 16899598 NP563591.RAGcDkMURkyB6Gv7lEN7lQVrjd5XVXqzVEDwk-vr7aGfo130_provenance.
- NP563591.RAGcDkMURkyB6Gv7lEN7lQVrjd5XVXqzVEDwk-vr7aGfo130_assertion wasDerivedFrom befree-2016 NP563591.RAGcDkMURkyB6Gv7lEN7lQVrjd5XVXqzVEDwk-vr7aGfo130_provenance.
- NP563591.RAGcDkMURkyB6Gv7lEN7lQVrjd5XVXqzVEDwk-vr7aGfo130_assertion wasGeneratedBy ECO_0000203 NP563591.RAGcDkMURkyB6Gv7lEN7lQVrjd5XVXqzVEDwk-vr7aGfo130_provenance.